Stocktoria
Vivani Medical, Inc. VANI
Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2014-12-05
Vivani Medical, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — | — | $3.4M | $6.9M | $8.0M | $4.0M |
| Gross profit | — | — | — | — | $130,000 | $500,000 | $1.2M | $2.0M | $2.8M | -$6.1M |
| R&D expense | $18.1M | $15.7M | $17.0M | $14.2M | $11.0M | $4.8M | $13.1M | $10.0M | $7.9M | $5.3M |
| Operating income | -$27.6M | -$24.7M | -$27.0M | -$21.2M | -$13.3M | -$14.9M | -$34.0M | -$35.2M | -$28.6M | -$33.2M |
| Income tax | — | $2,000 | — | — | — | — | $0 | $0 | — | — |
| Net income | -$26.6M | -$23.5M | -$25.7M | -$13.9M | -$12.8M | -$14.9M | -$33.6M | -$35.1M | -$28.5M | -$33.2M |
| EPS (diluted) | $-0.43 | $-0.43 | $-0.50 | — | — | — | — | — | — | — |
| Operating cash flow | -$24.3M | -$20.8M | -$23.7M | -$18.8M | -$11.0M | -$16.8M | -$27.6M | -$29.8M | -$23.9M | -$25.1M |
| Free cash flow | -$25.5M | -$21.3M | -$24.6M | -$19.1M | -$11.5M | -$17.2M | -$28.1M | -$30.0M | -$24.2M | -$25.6M |
| Cash & equivalents | $16.2M | $18.4M | $20.7M | $45.1M | $2.2M | $2.1M | $11.3M | $4.5M | $7.8M | $10.9M |
| Inventory | — | — | — | — | — | — | $1.0M | $3.2M | $2.7M | $3.4M |
| Total assets | $39.4M | $41.6M | $45.8M | $51.1M | $5.5M | $4.5M | $16.6M | $10.7M | $14.5M | $16.8M |
| Total liabilities | $23.7M | $24.0M | $25.0M | $6.8M | $3.0M | $5.1M | $9.3M | $7.6M | — | — |
| Shareholders' equity | $15.7M | $17.6M | $20.8M | $44.3M | $2.5M | $1.9M | $7.3M | $3.1M | $7.9M | $11.1M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | — | — | -51.0% | -13.4% | +99.1% | -55.1% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.